SARS-CoV-2 Vaccine Efficacy in Patients with Hematologic Malignancies: Practical Points for Further Research.

Guven, Deniz C; Sahin, Taha K; Akin, Serkan; Uckun, Fatih M

Guven, Deniz C; Sahin, Taha K; Akin, Serkan; Uckun, Fatih M.

Guven DC; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.
Sahin TK; Department of Internal Medicine, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Akin S; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.
Uckun FM; Bone Marrow Transplantation Unit, Hacettepe University Cancer Institute, Ankara, Turkey.

Oncologist ; 27(11): e917-e918, 2022 Nov 03.

Article in English | MEDLINE | ID: covidwho-2005010

Subject(s)

COVID-19; Hematologic Neoplasms; Humans; COVID-19 Vaccines/therapeutic use; SARS-CoV-2; Vaccine Efficacy; COVID-19/prevention & control; Hematologic Neoplasms/therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Hematologic Neoplasms / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Oncologist Journal subject: Neoplasms Year: 2022 Document Type: Article Affiliation country: Oncolo

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google